Skip to main content

Table 1 Interaction between resident liver cells and cancer cells

From: Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches

Resident cells

Interacting molecule(s)

Major effects

LSECs

Mannose receptor and scavenger receptor

Internalise, process and transfer antigens through MHC I and MHC II to T cells

PD-L1–PD-1

Induce CD8+ T-cell tolerance to trigger immune escape of cancer cells

IFNγ, NO and Fas–FasL

Induce apoptosis of cancer cells

CXCL16

Recruit NKT cells to fight cancer cells

E-selectin, VCAM-1, ICAM-1, sialyl Lewis-x, PSGL-1 and ESL-1

Facilitate the adherence of cancer cells to LSECs and their migration into the space of Disse to protect them from elimination

LSECtin

Suppress T-cell immune responses and promote the adhesion and metastasis of CRC to the liver

KCs

TNF-α, IL-1α and IL-1β

Phagocytose and eliminate disseminated cancer cells

MHC II and PD-L1–PD-1

Expand Treg cells to induce an immune-tolerant environment

TGF-β, fibronectin, EGF, VEGF, MMP-2, MMP-9 and MMP-13

Lead to ECM remodelling, angiogenesis and cancer progression

Exosomal miR-135a-5p

Mediate immunosuppression and facilitate the formation of a pre-metastatic niche

HSCs

TGF-β, fibronectin, EGF, VEGF, MMP-2, MMP-9, and MMP-13

Lead to ECM remodelling, angiogenesis and cancer progression

TGF-β

Promote ECM remodelling

Exosomal miR-181a-5p

Facilitate CRLM by activating HSCs

Hepatocytes

Integrins or desmosomes

Mediate the adhesion of CRC cells to hepatocytes

Integrins and heregulin

Boost the migration and LM of CRC

SAA

Reshape the hepatic immune and fibrogenic microenvironment to promote LM

IGF-1

Promote cancer growth and metastasis

  1. MHC I Major histocompatibility complex class I, MHC II Major histocompatibility complex class II, SAA Serum amyloid A1 and A2,  IGF-1 Insulin-like growth factor-I